Gecina (EPA:GFC)

Verve Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Property, Plant & Equipment	16,389	16,131	16,643	19,575	19,618	19,094
Cash & Equivalents	727.64	179.04	143.72	50.57	15.1	174.12
Accounts Receivable	54.11	31.49	35.4	33.33	39.35	51.31
Other Receivables	80.07	73.6	77.29	62.99	84.89	80.1
Investment In Debt and Equity Securities	2.12	2.22	1.84	1.73	11.16	1.25
Goodwill	165.76	165.76	165.76	183.22	184.66	191.08
Other Intangible Assets	11.14	11.66	12.78	13.53	10.61	9.01
Other Current Assets	367.61	1,031	217.5	263.68	259.87	439.56
Deferred Long-Term Tax Assets	0.89	0.89	0.89	1.16	1.67	1.9
Other Long-Term Assets	269.47	290.99	350.63	492.78	213.91	206.96
Total Assets	18,068	17,918	17,649	20,678	20,439	20,250
Current Portion of Long-Term Debt	106.13	557.02	49.6	355.04	613.83	286.89
Long-Term Debt	5,324	5,424	5,909	5,450	5,174	5,625
Long-Term Leases	49.44	49.64	49.61	50.07	50.57	50.72
Accounts Payable	66.54	50.21	49.04	49.19	57.06	61.46
Accrued Expenses	46.97	55.42	54.45	38.06	44.61	47.27
Current Income Taxes Payable	54.83	3.09	3.54	3.78	4.03	4.5
Current Unearned Revenue	9.06	13.74	9.22	2.18	3.4	2.51
Other Current Liabilities	506.7	306.84	282.45	282.98	278.18	241.92
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.06
Other Long-Term Liabilities	25.64	95.99	92.71	91.18	100.31	100.12
Total Liabilities	7,654	7,396	7,049	7,897	7,456	7,746
Common Stock	575.54	575.54	575.03	574.67	574.3	573.95
Additional Paid-In Capital	3,313	3,313	3,308	3,304	3,300	3,295
Retained Earnings	289.06	309.76	-1,787	169.58	849.29	155.07
Comprehensive Income & Other	6,221	6,308	8,487	8,709	8,233	8,453
Total Common Equity	10,398	10,506	10,583	12,757	12,956	12,477
Minority Interest	15.27	16.35	16.72	23.68	26.87	26.58
Shareholders' Equity	10,413	10,522	10,599	12,781	12,983	12,504
Total Liabilities & Equity	18,068	17,918	17,649	20,678	20,439	20,250
Total Debt	6,945	6,870	6,558	7,430	6,968	7,288
Net Cash (Debt)	-6,217	-6,691	-6,414	-7,379	-6,953	-7,114
Net Cash Per Share	-83.74	-90.20	-86.86	-99.80	-94.17	-96.52
Filing Date Shares Outstanding	74.02	73.95	73.88	73.8	73.71	73.62
Total Common Shares Outstanding	74.02	73.95	73.88	73.8	73.71	73.62
Book Value Per Share	140.48	142.07	143.24	172.86	175.76	169.48
Tangible Book Value	10,221	10,329	10,404	12,560	12,761	12,277
Tangible Book Value Per Share	138.09	139.67	140.83	170.19	173.12	166.76
Construction In Progress	871.43	1,212	1,398	1,354	1,545	1,257

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.